GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Aspen Pharmacare Holdings APN.JO · ZAc

Health Care · JSE · 🇿🇦 South Africa

Compare

16,886.00

+1.48%

Close of 9 Nov 2026, in ZAc

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Aspen Pharmacare Holdings

Its shares trade on JSE under the ticker APN.JO. It has been listed since 5 December 1994. In the fiscal year to 30 June 2026, it reported revenue of ZAR 34.87bn and net income of ZAR 2.65bn. At that date it held total assets of ZAR 108.27bn and shareholders' equity of ZAR 80.37bn.

Aspen Pharmacare Holdings Ltd. manufactures and supplies branded and generic pharmaceutical products. The company is headquartered in Durban, Kwazulu-Natal. The firm's segments include International, South Africa, Asia Pacific and Sub-Saharan Africa (SSA). Its International business includes operating subsidiaries in Europe, Commonwealth of Independent States (CIS), Latin America, the Middle East and North Africa, Canada, as well as Mauritius-based Aspen Global Incorporated. The South African business provides branded, generic, over-the-counter, consumer health and infant nutritional products, which are supplied to pharmacies, retail pharmacy chains, hospitals, clinics, prescribing specialists, dispensing general practitioners, managed healthcare funders and retail stores across the private and public sectors in South Africa. Its business in Asia Pacific includes operations in Australasia, the Philippines, Taiwan and Japan.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Pharmaceuticals
Listed since
5 Dec 1994
Employees
9,289

Leadership

Pay as last reported

  • Mr. Kuseni DlaminiIndependent Non-Executive Chairman of the BoardZAR 1.5m
  • Mr. Stephen SaadGroup Chief Executive, Executive DirectorZAR 28.2m
  • Mr. Sean CapazorioGroup Finance Officer, Executive Director, since 1999ZAR 21.9m
  • Mr. Chris BothaGroup Executive - Finance Manufacturing and Commercial Pharma
  • Mr. Samer KassemChief Executive Officer - Aspen Global Incorporated
  • Ms. Pauline MacdonaldGroup Executive - Supply Chain
  • Mr. Trevor ZimanRegional Chief Executive Officer - Asia Pacific
  • Ms. Lorraine HillGroup Chief Operations OfficerZAR 23.8m
  • Mr. Reginald HamanExecutive Director, Group Chief Corporate Officer, since 2020ZAR 11.9m
  • Mr. Michael AttridgeGroup Chief AdvisorZAR 12.6m
  • Mr. Carnie van der LindeSenior Group Executive - Commercial (International Regions)
  • Ms. Zizipho MmangoGroup Chief Strategic Development OfficerZAR 8.8m

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
78
Environment
73
Social
99
Governance
63
Direct emissions (scope 1)
37,424 t
Energy emissions (scope 2)
116,198 t
Value chain emissions (scope 3)
34,686 t
Women in the workforce
48%
Carbon reduction policy
Yes
Human rights policy
Yes

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Aspen Pharmacare Holdings Ltd has several strengths that contribute to its success in the pharmaceutical industry:

Weaknesses

  • Aspen Pharmacare Holdings Ltd also faces certain weaknesses that may hinder its performance:

Opportunities

  • Aspen Pharmacare Holdings Ltd can leverage the following opportunities to drive growth and expansion:

Threats

  • Aspen Pharmacare Holdings Ltd faces certain threats that may pose challenges to its operations:

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.